Genomic Health's Oncotype DX breast cancer recurrence score could help select more appropriate treatment for node-positive breast cancer patients, two studies have found. This means that some patients could be spared the debilitating side-effects of chemotherapy. Oncotype DX measures the ...
Please Login to read the full article.
